Cargando…
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma (CTCL) is a heterogenous disease that consists of distinct clinicopathologic entities and presentations requiring a unique and expert approach to management. The most common subtype is mycosis fungoides, in which local disease has an excellent prognosis and is often managed...
Autores principales: | Pelcovits, Ari, Ollila, Thomas A, Olszewski, Adam J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493109/ https://www.ncbi.nlm.nih.gov/pubmed/37700809 http://dx.doi.org/10.2147/CMAR.S330908 |
Ejemplares similares
-
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2019) -
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021) -
Advances in the understanding and treatment of Cutaneous T-cell Lymphoma
por: Bakr, Farrah S., et al.
Publicado: (2022) -
Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022) -
Locoregional gastric cancer: a narrative review of multidisciplinary management
por: Pelcovits, Ari, et al.
Publicado: (2020)